Table 4.
No. | Discovered Activity, (Pa) * | Reported Activity | Ref. |
---|---|---|---|
41 | Apoptosis agonist (0.950) Antihypercholesterolemic (0.931) Antineoplastic (0.886) Antieczematic (0.842) Atherosclerosis treatment (0.712) |
Cytotoxic | [160] |
42 | Apoptosis agonist (0.950) Antihypercholesterolemic (0.931) Antineoplastic (0.886) Antieczematic (0.842) Atherosclerosis treatment (0.712) |
Cytotoxic | [160] |
43 | Apoptosis agonist (0.954) Antineoplastic (0.914) Antihypercholesterolemic (0.906) Atherosclerosis treatment (0.741) |
Activity not studied | |
44 | Antihypercholesterolemic (0.934) Apoptosis agonist (0.929) Hypolipemic (0.864) Antineoplastic (0.861) |
Activity not studied | |
45 | Hepatoprotectant (0.994) Respiratory analeptic (0.990) Antihypercholesterolemic (0.897) |
Activity not studied | |
46 | Antihypercholesterolemic (0.900) Neuroprotector (0.749) Cholesterol synthesis inhibitor (0.636) |
Activity not studied | |
47 | Antihypercholesterolemic (0.901) Lipid metabolism regulator (0.833) Prostate disorders treatment (0.714) |
Anticancer | [165] |
48 | Antihypercholesterolemic (0.924) Lipid metabolism regulator (0.820) Neuroprotector (0.728) |
Anticancer | [165] |
* Only activities with Pa > 0.5 are shown.